The Vixarelimab Biosimilar Anti-OSMR Antibody is a cutting-edge research tool designed for studying the OSMR (Oncostatin M Receptor) pathway, an important signaling pathway involved in inflammation and immune responses. This biosimilar antibody is meticulously engineered to specifically target the OSMR protein, allowing for precise detection and analysis in various experimental settings.By utilizing the Vixarelimab Biosimilar Anti-OSMR Antibody, researchers can uncover valuable insights into the OSMR pathway's role in diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions.
Additionally, this antibody can aid in the development of novel therapeutic strategies aimed at modulating OSMR signaling for improved patient outcomes.With its high specificity and sensitivity, the Vixarelimab Biosimilar Anti-OSMR Antibody is a powerful tool for advancing research in immunology and oncology. Trust in this innovative antibody to accelerate your investigations and drive new discoveries in the field of molecular biology.
Product Name:
Vixarelimab (Anti-OSMR) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0126
Target:
OSMR
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
KPL-716
Description:
Anti-OSMR(vixarelimab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG4-lambda2
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
